South Korea vs Mus: Hypertension: effective treatment coverage (controlled) … 30-79
South Korea
55.4%
in 2019
Mus
35.4%
in 2019
South Korea rank
2nd
Mus rank
1st
Hypertension: effective treatment coverage (controlled) … 30-79 over time
- South Korea
- Mus
How they compare
South Korea currently reports 55.4% against 35.4% in Mus, a difference of 20.0%.
That makes South Korea's figure about 1.6 times Mus's.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Mus ahead.
South Korea ranks 2nd and Mus ranks 1st of 193 countries.
Across the 3 decades both report, South Korea averaged higher in 2 and Mus in 1.
Head to head by decade
| Decade | South Korea | Mus | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 7.4% | 7.8% | 0.3% | Mus |
| 2000s | 25.2% | 11.7% | 13.4% | South Korea |
| 2010s | 48.4% | 25.6% | 22.8% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension: effective treatment coverage (controlled hypertension), South Korea or Mus?
- South Korea, at 55.4% against 35.4% in Mus as of 2019.
- What is the difference in hypertension: effective treatment coverage (controlled hypertension) between South Korea and Mus?
- 20.0%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Mus?
- 30 years are reported by both, from 1990 to 2019.
- How do South Korea and Mus rank globally for hypertension: effective treatment coverage (controlled hypertension)?
- South Korea ranks 2nd and Mus ranks 1st of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.